Genetics in Disease

Search for Anti-Aging information and Medical News in Genetics in Disease within the Longevity and Age Management section

85 articles.
The drug methotrexate, first used in the 1940's, has been found to destroy the damaged MSH2 gene prevelant in people with the genetic condition HNPCC. HNPCC contributes to bowel cancer, tumors of the stomach, womb, ovaries and kidneys. Continue reading…
Posted on 2009-09-01 21:47:19 in Cancer | Genetic Research | Genetics in Disease | Longevity and Age Management |
Melanoma tumors with particular genetic mutations might respond to the drug lapatinib, already licensed for treating breast cancer tumors. Such a therapy would treat malignant melanoma in advanced stages with the common mutation called ERBB4 or HER4. Continue reading…
Posted on 2009-09-01 21:09:19 in Cancer | Genetic Research | Genetics in Disease | Longevity and Age Management |
A report in "The Federation of American Societies for Experimental Biology Journal" describes a new gene therapy vector which can transfer DNA to a cell's nucleus far more efficiently than in the past. The development raises hopes for more effective treatment of genetic disorders and some types of cancers. Continue reading…


Highlights from a presentation given by Mitchell J. Ghen, DO, PhD at the 17th Annual World Congress on Anti-Aging and Regenerative Medicine entitled, Regenerative Medicine Update: Stem Cells and Functional Testing

Dr. Ghen will be presenting several sessions at the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures, He will also act as Moderator at the Global Stem Cell Symposium to be held during the conference on Saturday September 12th, 2009.

For more information, call; 1-888-997-0112. Continue reading…
Kyle Knopes, who has been living with Type 2 spinal muscular atrophy since he was a baby, traveled to China to undergo stem cell injections, which he and his family say have improved his quality of life. Brooke Barels has also seen improvements after receiving injections for a genetic disorder during two different trips to China. Continue reading…
Researchers from the Harvard Medical School have developed a new automated multiplex technology that will enable biotech labs to engineer entire pathways and genomes at an unprecedented rate, catapulting cell programming to a whole new level. Continue reading…
Physicians from Jewish Hospital conducted the first adult cardiac stem cell procedure on a 66-year-old man, who, as a result of congestive heart failure, had permanent scarring on his heart muscle. Continue reading…

Week of July 13, 2009

William H. Andrews, PhD

Dr. Andrews leads the scientific research and development function of Sierra Sciences. His team is now pursuing direct molecular approaches to temporarily activate telomerase expression, and is performing high‐throughput screening and drug discovery efforts.

While Director of Molecular Biology at Geron Corporation, he was one of the principal discoverers of the telomerase genes. He was awarded 2nd place as "National Inventor of the Year" in 1997 for this work, with his name appearing on numerous related patents and publications. He earned his Ph.D. in Molecular and Population Genetics at the University of Georgia. He has more than 25 refereed publications and abstracts.

At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Andrews will present, Telomerase Activation: The Future of Anti‐Aging Medicine, on Friday, September 11th.

For more information call the A4M today; 1-888-997-0112. Continue reading…

Posted on 2009-07-14 10:11:43 in Cancer | Genetic Research | Genetics in Disease | Longevity and Age Management |
Examining micro RNA molecules, the “master switches” for an individual's genes, is helping Connecticut scientists gain a new understanding of biology and cancer, which could ultimately lead to a cure for the disease. Continue reading…
Posted on 2009-07-09 09:33:45 in Cancer | Genetic Research | Genetics in Disease | Longevity and Age Management |
According to a study published in Nature Genetics, the first genetic variants associated with an increased risk of developing glioma, the most common form of brain cancer, have been identified. Continue reading…
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health (PATH Medical), Chairs the Brain Age Workshop taking place Dec. 9, 2009. Held in conjunction with the Winter Session of the 17th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The Brain Age Workshop features presentations on Brain Mind Assessment via Neuropsychological Analysis, Movement Deficiency Syndrome, Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain Injury. View this video to learn about Dr. Braverman’s brain-based model of aging and age modulation.

International Events
See all events »